Explore our web companion for the video featuring insights from Roshni Rao, MD FACS, Chief of Breast Surgery at Columbia University.…
Browsing: ASBrS
At the ASBrS 2025 annual meeting, Dr. Lucy Maria De La Cruz, MD, from Georgetown University Hospital, shared vital insights…
What Are CDK4/6 Inhibitors? CDK4/6 inhibitors, such as abemaciclib and ribociclib, are changing breast cancer treatment for HR+/HER2- early-stage patients.…
Sensation-preserving mastectomies are transforming breast cancer surgery. They prioritize oncologic safety and sensory recovery. In an exclusive interview, Dr. Anne…
A major study, NRG-NSABP B-51/RTOG 1304, published on June 4, 2025, in the New England Journal of Medicine, shows regional…
Breast surgery is transforming patient care with innovative approaches. Oncoplastic breast surgery, for instance, merges art and science to improve…
At ASBrS 2025, experts showcased how MRD testing in breast cancer is revolutionizing patient care. Using Natera’s Signatera, clinicians detect circulating tumor…